GlassScriptPhysician profile
Aditya Parikh
NPI 1588939938
$31,080.89
in general payments reported to CMS, 2019-2025
22 companies · $1,746 in 2025
The $1,746 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $1,430 · 2021: $863 · 2022: $3,201 · 2023: $6,819 · 2024: $17K · 2025: $1,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,858 · Consulting Fee: $8,700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $2,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,858.13 |
| Consulting Fee | $8,700.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $2,652.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26,387.59 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Triclip |
| Transmedics, INC. | $1,458.31 | 2025 | Organ Care System |
| Impulse Dynamics (USA) INC. | $766.75 | 2023-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $370.22 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $321.36 | 2019-2024 | |
| Abiomed | $260.82 | 2022-2025 | Impella |
| Endotronix, INC. | $223.00 | 2022-2024 | Cordella Pulomonary Artery Pressure Sensor |
| E.R. Squibb & Sons, L.L.C. | $178.01 | 2022-2023 | Camzyos |
| Baxter Healthcare | $175.88 | 2022 | |
| Biotronik INC. | $160.02 | 2019 | |
| Novo Nordisk INC | $149.83 | 2021-2023 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.36 | 2021-2022 | |
| Amgen INC. | $89.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $85.23 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $68.15 | 2020-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $62.84 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $44.95 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.45 | 2023-2024 | Lifevest |
| Cvrx, INC. | $28.20 | 2025 | Barostim Neo System |
| One Lambda, INC. | $27.84 | 2025 | |
| Pfizer INC. | $18.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.